Arnout Bruggeman

538 total citations · 1 hit paper
15 papers, 366 citations indexed

About

Arnout Bruggeman is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Arnout Bruggeman has authored 15 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Neurology and 3 papers in Neurology. Recurrent topics in Arnout Bruggeman's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Extracellular vesicles in disease (3 papers) and Gut microbiota and health (3 papers). Arnout Bruggeman is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Extracellular vesicles in disease (3 papers) and Gut microbiota and health (3 papers). Arnout Bruggeman collaborates with scholars based in Belgium, United States and Germany. Arnout Bruggeman's co-authors include Roosmarijn E. Vandenbroucke, Charysse Vandendriessche, Caroline Van Cauwenberghe, Elien Van Wonterghem, Griet Van Imschoot, Junhua Xie, Alain Rabaute, Lars Vereecke, Pieter Van Rensbergen and Patrick Santens and has published in prestigious journals such as The EMBO Journal, International Journal of Molecular Sciences and Cells.

In The Last Decade

Arnout Bruggeman

13 papers receiving 363 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial

2024 65 citations Arnout Bruggeman, Charysse Vandendriessche et al. EClinicalMedicine profile →

Peers

Arnout Bruggeman

NEURO

PHYSI

NEURO

Huanhuan Sun China

XH Li China

Zachary Thomson United States

Michitaka Tanaka Japan

Wenyu Jiang China

Joy Guingab‐Cagmat United States

Xilei Liu China

Chunyan Wang China

Anna Aureli Italy

Yanan Pan China

Huanhuan Sun China

Arnout Bruggeman

157 ×0.8

43 ×0.6

NEURO

54 ×0.8

PHYSI

53 ×1.2

NEURO

19 ×0.5

Citations per year, relative to Arnout Bruggeman Arnout Bruggeman (= 1×) peers Huanhuan Sun

Countries citing papers authored by Arnout Bruggeman

Since Specialization

Citations

This map shows the geographic impact of Arnout Bruggeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnout Bruggeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnout Bruggeman more than expected).

Fields of papers citing papers by Arnout Bruggeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnout Bruggeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnout Bruggeman. The network helps show where Arnout Bruggeman may publish in the future.

Co-authorship network of co-authors of Arnout Bruggeman

This figure shows the co-authorship network connecting the top 25 collaborators of Arnout Bruggeman. A scholar is included among the top collaborators of Arnout Bruggeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnout Bruggeman. Arnout Bruggeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vandendriessche, Charysse, Arnout Bruggeman, Lien Van Hoecke, et al.. (2024). The Spreading and Effects of Human Recombinant α-Synuclein Preformed Fibrils in the Cerebrospinal Fluid of Mice. eNeuro. 11(3). ENEURO.0024–23.2024. 3 indexed citations

Bruggeman, Arnout, Charysse Vandendriessche, Danny De Looze, et al.. (2024). Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial. EClinicalMedicine. 71. 102563–102563. 65 indexed citations breakdown →

Xie, Junhua, Arnout Bruggeman, Charysse Vandendriessche, et al.. (2023). Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology. The EMBO Journal. 42(17). e111515–e111515. 66 indexed citations

Truyens, Marie, Charysse Vandendriessche, Arnout Bruggeman, et al.. (2023). P014 Behaviour in mice with chronic DSS colitis mimics fatigue in IBD and is associated with neuroinflammation. Journal of Crohn s and Colitis. 17(Supplement_1). i184–i184.

Santens, Patrick, et al.. (2022). Marked hypotonia: An additional feature of ANO3-related movement disorder. European Journal of Medical Genetics. 65(12). 104625–104625. 1 indexed citations

Bruggeman, Arnout, Charysse Vandendriessche, Junhua Xie, et al.. (2021). Gastric Helicobacter suis Infection Partially Protects against Neurotoxicity in A 6-OHDA Parkinson’s Disease Mouse Model. International Journal of Molecular Sciences. 22(21). 11328–11328. 4 indexed citations

Vandendriessche, Charysse, Sriram Balusu, Caroline Van Cauwenberghe, et al.. (2021). Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease. Acta Neuropathologica Communications. 9(1). 143–143. 41 indexed citations

Hoecke, Lien Van, Caroline Van Cauwenberghe, Verena Börger, et al.. (2021). Anti-Inflammatory Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Pathology in Niemann–Pick Type C Disease. Biomedicines. 9(12). 1864–1864. 21 indexed citations

Bruggeman, Arnout, et al.. (2021). Reversible Drug‐Induced Pisa Syndrome Due to a Cholinesterase Inhibitor. Movement Disorders Clinical Practice. 8(6). 961–962. 3 indexed citations

10.

Ghyselinck, Jonas, Lynn Verstrepen, Frédéric Moens, et al.. (2021). Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease. International Journal of Pharmaceutics X. 3. 100087–100087. 41 indexed citations

11.

Santens, Patrick & Arnout Bruggeman. (2021). Posttraumatic functional movement disorders and litigation. Acta Neurologica Belgica. 121(3). 643–647.

12.

Vandendriessche, Charysse, Arnout Bruggeman, Caroline Van Cauwenberghe, & Roosmarijn E. Vandenbroucke. (2020). Extracellular Vesicles in Alzheimer’s and Parkinson’s Disease: Small Entities with Large Consequences. Cells. 9(11). 2485–2485. 45 indexed citations

13.

Letter, Miet De, et al.. (2020). Subthalamic nucleus activity in the processing of body and mental action verbs in people with Parkinson’s disease. Brain and Language. 202. 104738–104738. 3 indexed citations

14.

Rensbergen, Pieter Van, et al.. (2005). Fluid migration and fluid seepage in the Connemara Field, Porcupine Basin interpreted from industrial 3D seismic and well data combined with high-resolution site survey data. International Journal of Earth Sciences. 96(1). 185–197. 50 indexed citations

15.

Smit, Martine J., Cor J. Vink, Dennis Verzijl, et al.. (2003). Virally Encoded G Protein-Coupled Receptors: Targets for Potentially Innovative Anti-Viral Drug Development. Current Drug Targets. 4(5). 431–441. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact